Efficacy and Safety of Lorundrostat Alone, and in Combination With Dapagliflozin in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria

Conditions: Chronic Kidney Disease Interventions: Drug: Part A - Lorundrostat QD + Dapaglifozin QD; Drug: Part A - Lorundrostat QD; Drug: Part B - Lorundrostat QD Open Label Sponsors: Mineralys Therapeutics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials